Advanced search
Publication Cover
International Medical Case Reports Journal Volume 13, 2020 - Issue
Submit an article Journal homepage
142
Views
11
CrossRef citations to date
0
Altmetric
Case report

CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity

Silvana Guerriero1 Department of Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
,
Francesco D’Oria1 Department of Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
,
Giacomo Rossetti2 Department of Molecular Biology, University of Geneva, Geneva, Switzerland
,
Rosa Anna Favale1 Department of Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
,
Stefano Zoccolella1 Department of Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
,
Giovanni Alessio1 Department of Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, ItalyORCID Iconhttps://orcid.org/0000-0001-8313-4159
ORCID Icon &
Vittoria Petruzzella1 Department of Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8771-6033
ORCID Icon show all
Pages 41-45 | Published online: 20 Feb 2020

References

  • Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth disease. Clin Genet. 1974;6:98–118.
  • Züchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol. 2006;59:276–281. doi:10.1002/(ISSN)1531-8249
  • Engelfried K, Vorgerd M, Hagedorn M, et al. Charcot–Marie–Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). BMC Med Genet. 2006;7:53.
  • Tan CA, Rabideau M, Blevins A, et al. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: case report and literature review. Am J Med Genet Part A. 2016;170:1580–1584. doi:10.1002/ajmg.a.37611
  • Stuppia G, Rizzo F, Riboldi G, et al. MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives. J Neurol Sci. 2015;356:7–18. doi:10.1016/j.jns.2015.05.033
  • Ando M, Hashiguchi A, Okamoto Y, et al. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. J Peripher Nerv Syst. 2017;22:191–199. doi:10.1111/jns.2017.22.issue-3
  • Filadi R, Pendin D, Pizzo P. Mitofusin 2: from functions to disease. Cell Death Dis. 2018;9:330. doi:10.1038/s41419-017-0023-6
  • El-Hattab AW, Suleiman J, Almannai M, et al. Mitochondrial dynamics: biological roles, molecular machinery, and related diseases. Mol Genet Metab. 2018;125:315–321. doi:10.1016/j.ymgme.2018.10.003
  • Rouzier C, Bannwarth S, Chaussenot A, et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy “plus” phenotype. Brain J Neurol. 2012;135:23–34. doi:10.1093/brain/awr323
  • Bombelli F, Stojkovic T, Dubourg O, et al. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features. JAMA Neurol. 2014;71:1036–1042. doi:10.1001/jamaneurol.2014.629
  • Leonardi L, Marcotulli C, Storti E, et al. Acute optic neuropathy associated with a novel MFN2 mutation. Neurol. 2015;262:1678–1680. doi:10.1007/s00415-015-7756-x
  • Bianco, A., Bisceglia, L., De Caro, M.F. et al. Leber’s hereditary optic neuropathy, intellectual disability and epilepsy presenting with variable penetrance associated to the m.3460G>A mutation and a heteroplasmic expansion of the microsatellite in MTRNR1 gene – case report. BMC Med Genet 19. 2018;129. doi:10.1186/s12881-018-0644-3
  • Iapadre G, Morana G, Vari MS, Pinto F, et al. A novel homozygous MFN2 mutation associated with severe and atypical CMT phenotype. Eur J Paediatr Neurol. 2018;22:563–567. doi:10.1016/j.ejpn.2017.12.020
  • Wu R, Fu J, Meng L, et al. Late-onset hereditary sensory and autonomic neuropathy expands the phenotypic spectrum of MFN2-related diseases. Neuropathology. 2018;38:463–467. doi:10.1111/neup.12487
  • Dankwa L, Richardson J, Motley WW, et al. A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family. Neuromuscul Disord. 2019;29:134–137. doi:10.1016/j.nmd.2018.12.008
  • Devine MJ, Kittler JT. Mitochondria at the neuronal presynapse in health and disease. Nat Rev Neurosci. 2018;19:63–80. doi:10.1038/nrn.2017.170
  • Chandhok G, Lazarou M, Neumann B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2018;93:933–949. doi:10.1111/brv.12378

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.